Teva Pharmaceutical Industries (TEVA) Dividend Coverage Ratio Growth (3y) (2012 - 2018)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Dividend Coverage Ratio Growth (3y) (2012 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.98 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | -35.05% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 522.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.65 Mn | 365.40 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | 285.22% |
| Dec 31, 2017 | -390.30% |
| Sep 30, 2017 | 13.43% |
| Jun 30, 2017 | -108.17% |
| Mar 31, 2017 | -13.28% |
| Dec 31, 2016 | -5.81% |
| Sep 30, 2016 | -27.63% |
| Jun 30, 2016 | 33.12% |
| Mar 31, 2016 | -6.87% |
| Dec 31, 2015 | 42.27% |
| Sep 30, 2015 | 46.11% |
| Jun 30, 2015 | -20.94% |
| Mar 31, 2015 | -32.42% |
| Dec 31, 2014 | 79.36% |
| Sep 30, 2014 | -13.64% |
| Jun 30, 2014 | -5.00% |
| Mar 31, 2014 | -12.54% |
| Dec 31, 2013 | -42.05% |
| Sep 30, 2013 | -24.60% |
| Jun 30, 2013 | -32.81% |